A phase 1 randomized, double-blind, placebo-controlled study of VAS101 on knee pain in adult patients with chronic knee osteoarthritis
Latest Information Update: 06 Oct 2025
At a glance
- Drugs Curcumin (Primary)
- Indications Pain
- Focus Adverse reactions
Most Recent Events
- 29 Sep 2025 Status changed from recruiting to completed.
- 29 Sep 2025 Vascarta Announces Completion of Phase 1 Clinical Trial of VAS-101 for the Treatment of Osteoarthritis.
- 20 Mar 2025 New trial record